The information on COVID-19 and substance use in this section focuses on activities and procedures that people and service providers might consider once measures to contain the virus, such as physical distancing, are relaxed. Resources are classified according to their focus on Resuming Activities, Substances, Harm Reduction and Treatment, Policies and Guides, and Academic Publications.
CCSA cannot vouch for the accuracy or currency of the information in these resources. Inclusion of a resource on this page does not imply endorsement or authorization by CCSA.
Academic Publication
Academic Publication
| Resource | Organization |
|---|---|
| Mitigating and learning from the impact of COVID-19 infection on addictive disorders | Addiction |
| COVID-19 and people who use drugs: a call for action | Canadian Journal of Public Health |
| Public health policies can reduce inequalities as we come out of lockdown | BMJ |
| COVID ‐19 and alcohol in Australia: Industry changes and public health impacts | Drug and Alcohol Review |
| COVID-19 - Enacting a ‘new normal’ for people who use drugs | International Journal of Drug Policy |
| Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption | JAMA Psychiatry |
| Opioid Policy Changes During the COVID-19 Pandemic - and Beyond | Journal of Addiction Medicine |
Harm Reduction & Treatment
Harm Reduction & Treatment
| Resource | Organization |
|---|---|
| World Drug Report 2020: Executive Summary Impact of COVID-19 | EurekALERT |
| EMCDDA trendspotter briefing - May 2020 - Impact of COVID-19 on drug services and help-seeking in Europe | European Monitoring Centre for Drugs and Drug Addiction |
| Telehealth Must Stay After COVID-19 to Save Our Patients From Overdose | Filter Magazine |
| COVID-19 - Enacting a ‘new normal’ for people who use drugs | International Journal of Drug Policy |
| Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption | JAMA Psychiatry |
| Opioid Policy Changes During the COVID-19 Pandemic - and Beyond | Journal of Addiction Medicine |
| Supervised Dispensing after COVID-19 | National Health Service Substance Misuse Provider Alliance |
| With You through COVID-19: crisis and recovery | We Are With You |
Resuming Activities
Resuming Activities
| Resource | Organization |
|---|---|
| Getting Back on the Road Impaired Driving Risks (Infographic) | Canadian Centre on Substance Use and Addiction |
| EMCDDA trendspotter briefing - May 2020 - Impact of COVID-19 on drug services and help-seeking in Europe | European Monitoring Centre for Drugs and Drug Addiction |
| Telehealth Must Stay After COVID-19 to Save Our Patients From Overdose | Filter Magazine |
| Isolation is a prescription for coronavirus, but a threat to addiction treatment in the Lehigh Valley | The Morning Call (Pennsylvania) |
| With You through COVID-19: crisis and recovery | We Are With You |
| COVID-19 et la phase de rétablissement à la pandémie pour les personnes avec des problèmes de dépendance ou en situation d’itinérance (in French only) | Institut national d'excellence en santé et en services sociaux |
Substances
Substances
| Resource | Organization |
|---|---|
| Getting Back on the Road Impaired Driving Risks (Infographic) | Canadian Centre on Substance Use and Addiction |
| COVID ‐19 and alcohol in Australia: Industry changes and public health impacts | Drug and Alcohol Review |
| COVID-19 et la phase de rétablissement à la pandémie pour les personnes avec des problèmes de dépendance ou en situation d’itinérance (in French only) | Institut national d'excellence en santé et en services sociaux |